Esperion Therapeutics Inc (NASDAQ: ESPR) kicked off on Tuesday, up 16.40% from the previous trading day, before settling in for the closing price of $3.17. Over the past 52 weeks, ESPR has traded in a range of $0.69-$3.94.
Healthcare Sector giant saw their annual sales surged by 40.11% over the last five years. While this was happening, its average annual earnings per share was recorded 57.54%. With a float of $234.63 million, this company’s outstanding shares have now reached $239.06 million.
Esperion Therapeutics Inc (ESPR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Esperion Therapeutics Inc is 1.86%, while institutional ownership is 53.00%. The most recent insider transaction that took place on Oct 17 ’25, was worth 3,275. Before that another transaction happened on Sep 17 ’25, when Company’s General Counsel sold 6,267 for $2.80, making the entire transaction worth $17,573. This insider now owns 393,670 shares in total.
Esperion Therapeutics Inc (ESPR) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.1 earnings per share (EPS), higher than consensus estimate (set at -0.16) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.54% per share during the next fiscal year.
Esperion Therapeutics Inc (NASDAQ: ESPR) Trading Performance Indicators
Take a look at Esperion Therapeutics Inc’s (ESPR) current performance indicators. Last quarter, stock had a quick ratio of 0.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.54, a number that is poised to hit 0.29 in the next quarter and is forecasted to reach 0.07 in one year’s time.
Technical Analysis of Esperion Therapeutics Inc (ESPR)
Analysing the last 5-days average volume posted by the [Esperion Therapeutics Inc, ESPR], we can find that recorded value of 8.93 million was better than the volume posted last year of 5.5 million. As of the previous 9 days, the stock’s Stochastic %D was 82.74%.
During the past 100 days, Esperion Therapeutics Inc’s (ESPR) raw stochastic average was set at 97.00%, which indicates a significant increase from 94.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.81, while its 200-day Moving Average is $1.79. Now, the first resistance to watch is $3.88. This is followed by the second major resistance level at $4.07. The third major resistance level sits at $4.37. If the price goes on to break the first support level at $3.39, it is likely to go to the next support level at $3.09. Now, if the price goes above the second support level, the third support stands at $2.90.
Esperion Therapeutics Inc (NASDAQ: ESPR) Key Stats
The company with the Market Capitalisation of 882.14 million has total of 239,063K Shares Outstanding. Its annual sales at the moment are 332,310 K in contrast with the sum of -51,750 K annual income. Company’s last quarter sales were recorded 87,310 K and last quarter income was -31,330 K.
